2015 Progress Report
Progress in MS Research
In 2015, the Alliance awarded 22 Challenge Awards of €75,000, designed to improve understanding of genetic and biological processes, repurpose existing drugs and speed up clinical trials. These 1–2 year research projects began in 2015, and are focused on six areas:
- Clinical trials and outcome measures
- Biomarkers of progression
- Gene studies
- Rehabilitation trials
- Underlying pathology of progression
- Developing new disease models
Planning grants in support of the Collaborative Network Awards
The second global Request for Applications for Collaborative Network Planning Grants generated 52 applications representing more than 500 researchers from around the world. Following an extensive peer and technical review involving key academic and industry experts, 11 projects received a 12 month €50,000 planning grant.
Planning award networks involve 139 investigators from 17 countries including: Austria, Canada, the Czech Republic, Denmark, Finland, France, Germany, Ireland, Israel, Italy, the Netherlands, Spain, Sweden, Switzerland, the UK and the US.
Expanding Alliance Membership
Four new members joined the Alliance in 2015: L’Association pour l’aide à la recherche sur la sclérose en plaques (France), La Ligue Française contre la Sclérose en Plaques (France), Multipel Sklerose Forbundet i Norge (Norway) and The MS Society of Ireland (Ireland).
To read more about the great progress made this year, please download the report below:
Sign up to our e-newsletterfor updates from our growing global initiative to end progressive MS
Clicking submit confirms that you consent to MSIF sending you the Progressive MS Alliance newsletter
Please note, you must be aged 18 or older to subscribe to our newsletters.